TY - JOUR
T1 - TIPICO IX
T2 - report of the 9th interactive infectious disease workshop on infectious diseases and vaccines
AU - Martinón-Torres, Federico
AU - Bosch, Xavier
AU - Rappuoli, Rino
AU - Findlow, Jamie
AU - Ladhani, Shamez
AU - Redondo, Esther
AU - Vesikari, Timo
AU - García-Sastre, Adolfo
AU - Rivero-Calle, Irene
AU - Gómez-Rial, José
AU - Salas, Antonio
AU - Martín, Carlos
AU - Finn, Adam
AU - Butler, Robb
PY - 2019/6/3
Y1 - 2019/6/3
N2 - The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22–23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.
AB - The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22–23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.
KW - synthetic biology
KW - infectious diseases
KW - vaccines
KW - vaccinomics
KW - vaccine hesitancy
KW - infectomics
KW - TIPICO
U2 - 10.1080/21645515.2019.1609823
DO - 10.1080/21645515.2019.1609823
M3 - Article (Academic Journal)
C2 - 31158041
SN - 2164-5515
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
ER -